Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Aeterna Zentaris Inc T.AEZS

Alternate Symbol(s):  AEZS

Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The... see more

Recent & Breaking News (TSX:AEZS)

Aeterna Zentaris Reports First Quarter 2019 Financial and Operating Results

GlobeNewswire May 7, 2019

50 Biggest Movers From Yesterday

Benzinga.com  April 12, 2019

The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership

Benzinga.com  April 5, 2019

The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial

Benzinga.com  April 2, 2019

62 Biggest Movers From Friday

Benzinga.com  April 1, 2019

Aeterna Zentaris Reports Fourth Quarter and Full-Year 2018 Financial and Operating Results

GlobeNewswire March 26, 2019

Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019

GlobeNewswire March 19, 2019

IIROC Trade Resumption - AEZS

Canada NewsWire March 13, 2019

The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie

Benzinga.com  March 13, 2019

Aeterna Zentaris Announces Strategic Review and Engagement of Financial Advisor

GlobeNewswire March 12, 2019

IIROC Trading Halt - AEZS

Canada NewsWire March 12, 2019

The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results

Benzinga.com  February 5, 2019

58 Biggest Movers From Yesterday

Benzinga.com  January 17, 2019

Aeterna Zentaris Receives European Marketing Clearance for Macimorelin

GlobeNewswire January 16, 2019

Aeterna Zentaris Settles Dispute with David Dodd and Philip Theodore

GlobeNewswire December 21, 2018

The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO

Benzinga.com  December 4, 2018

Aeterna Zentaris (AEZS) Receives Positive CHMP Opinion of Macimorelin for Diagnosis of Adult Growth Hormone Deficiency

GlobeNewswire November 19, 2018

55 Biggest Movers From Friday

Benzinga.com  November 19, 2018

Consolidated Research: 2018 Summary Expectations for Western Gas Partners, LP, HCA Healthcare, DHI Group, AEterna Zentaris, Tsakos Energy Navigation, and Acme United — Fundamental Analysis, Key Performance Indications

GlobeNewswire November 16, 2018

Aeterna Zentaris Reports Third Quarter 2018 Financial and Operating Results

GlobeNewswire November 6, 2018